... Industries Ltd (ADR) (NYSE:TEVA). These stocks are Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY), Pharmacyclics, Inc. (NASDAQ:PCYC), Forest Laboratories, Inc. (NYSE:FRX), Novo Nordisk A/S (ADR) (NYSE:NVO), and Allergan, Inc. (NYSE:AGN).

Novo Nordisk A/S (NVO, NOVO-B.KO), the world's top maker of insulin, said its hotly anticipated Tresiba drug may not hit the U.S.

Zacks' analyst wrote, �Novo Nordisk posted first quarter 2013 earnings of $1.94 per ADR, up 32.5% from the year-ago period.